Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Append Prague Study

NCT: NCT07816029 · RECRUITING

NCT IDNCT07816029
StatusRECRUITING
Start Date2025-07-16
Completion2033-06
SponsorAppend Medical Ltd. (INDUSTRY)
First posted
Last updated

Brief Summary

This study is intended to evaluate the safety and feasibility of the Append System for left atrial appendage (LAA) elimination using a transcatheter procedure that invaginates and ligates the LAA tissue.

Frequently Asked Questions

What is Append Prague Study?

Append Prague Study is a clinical trial registered under NCT07816029. Current status: RECRUITING.

What is the status of NCT07816029?

The current status of NCT07816029 (Append Prague Study) is: RECRUITING.

When did Append Prague Study start?

Append Prague Study started on 2025-07-16.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.